Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fritsche

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
Diagnostic Microbiology and Infectious Disease|August 26, 2006
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)Ronald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|November 5, 2003
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002)Helio S Sader, Thomas R Fritsche, Alan H Mutnick, et al.
Journal of Clinical Microbiology|April 4, 2000
Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficileA P Limaye, D K Turgeon, B T Cookson, et al.
Diagnostic Microbiology and Infectious Disease|February 10, 2006
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|January 26, 2006
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocolR N Jones, T R Fritsche, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2006
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)David M Johnson, Matthew G Stilwell, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2004
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolatesHelio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2004
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesJennifer M Streit, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004)P R Rhomberg, T R Fritsche, H S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003H S Sader, T R Fritsche, J M Streit, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
Diagnostic Microbiology and Infectious Disease|August 26, 2006
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004)Ronald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|November 5, 2003
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002)Helio S Sader, Thomas R Fritsche, Alan H Mutnick, et al.
Journal of Clinical Microbiology|April 4, 2000
Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficileA P Limaye, D K Turgeon, B T Cookson, et al.
Diagnostic Microbiology and Infectious Disease|February 10, 2006
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)Paul R Rhomberg, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|January 26, 2006
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocolR N Jones, T R Fritsche, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2006
Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003)David M Johnson, Matthew G Stilwell, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|August 18, 2004
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolatesHelio S Sader, Jennifer M Streit, Thomas R Fritsche, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2004
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolatesJennifer M Streit, Thomas R Fritsche, Helio S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004)P R Rhomberg, T R Fritsche, H S Sader, et al.
Journal of Chemotherapy (Florence, Italy)|December 6, 2005
Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003H S Sader, T R Fritsche, J M Streit, et al.
Pageof 22